Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
Epidemics
|
June 28, 2023
Reconstruction of SARS-CoV-2 outbreaks in a primary school using epidemiological and genomic data
Cécile Kremer, Andrea Torneri, Pieter J K Libin, et al.
Vaccines
|
September 23, 2022
The Dynamic Relationship between the Intention and Final Decision for the COVID-19 Booster: A Study among Students and Staff at the University of Liège, Belgium
Marine Paridans, Justine Monseur, Anne-Françoise Donneau, et al.
Acta Clinica Belgica
|
May 30, 2024
A characterization of the HIV population with limited/exhausted treatment options: a multicenter Belgian study
Rakan Nasreddine, Gilles Darcis, Jean Cyr Yombi, et al.
HIV Medicine
|
April 10, 2023
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium
Rakan Nasreddine, Eric Florence, Jean Cyr Yombi, et al.
Open Forum Infectious Diseases
|
November 18, 2020
Evolution of Drug Interactions With Antiretroviral Medication in People With HIV
Majdouline El Moussaoui, Iseult Lambert, Nathalie Maes, et al.
Acta Clinica Belgica
|
June 18, 2017
Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study
Jessie Gunter, Steven Callens, Stephane De Wit, et al.
Virus Evolution
|
October 14, 2024
Intrahost evolution leading to distinct lineages in the upper and lower respiratory tracts during SARS-CoV-2 prolonged infection
Majdouline El Moussaoui, Sebastien Bontems, Cecile Meex, et al.
Pathogens (Basel, Switzerland)
|
November 27, 2021
In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2
Justine Defêche, Samira Azarzar, Alyssia Mesdagh, et al.
HIV Medicine
|
August 8, 2022
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium
Rakan Nasreddine, Jean Cyr Yombi, Gilles Darcis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 16, 2019
Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments
Anna Kula, Nadège Delacourt, Sophie Bouchat, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
Epidemics
|
June 28, 2023
Reconstruction of SARS-CoV-2 outbreaks in a primary school using epidemiological and genomic data
Cécile Kremer, Andrea Torneri, Pieter J K Libin, et al.
Vaccines
|
September 23, 2022
The Dynamic Relationship between the Intention and Final Decision for the COVID-19 Booster: A Study among Students and Staff at the University of Liège, Belgium
Marine Paridans, Justine Monseur, Anne-Françoise Donneau, et al.
Acta Clinica Belgica
|
May 30, 2024
A characterization of the HIV population with limited/exhausted treatment options: a multicenter Belgian study
Rakan Nasreddine, Gilles Darcis, Jean Cyr Yombi, et al.
HIV Medicine
|
April 10, 2023
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium
Rakan Nasreddine, Eric Florence, Jean Cyr Yombi, et al.
Open Forum Infectious Diseases
|
November 18, 2020
Evolution of Drug Interactions With Antiretroviral Medication in People With HIV
Majdouline El Moussaoui, Iseult Lambert, Nathalie Maes, et al.
Acta Clinica Belgica
|
June 18, 2017
Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study
Jessie Gunter, Steven Callens, Stephane De Wit, et al.
Virus Evolution
|
October 14, 2024
Intrahost evolution leading to distinct lineages in the upper and lower respiratory tracts during SARS-CoV-2 prolonged infection
Majdouline El Moussaoui, Sebastien Bontems, Cecile Meex, et al.
Pathogens (Basel, Switzerland)
|
November 27, 2021
In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2
Justine Defêche, Samira Azarzar, Alyssia Mesdagh, et al.
HIV Medicine
|
August 8, 2022
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium
Rakan Nasreddine, Jean Cyr Yombi, Gilles Darcis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 16, 2019
Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments
Anna Kula, Nadège Delacourt, Sophie Bouchat, et al.
Page
of 9